Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.36 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.34 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TLR4 | O00206 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.31 |
| ▸ | TUBB | P07437 | 1/20 | 0.31 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20706789 | 0.96 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMPTGER4DUSP3 | |
| SCHEMBL20149453 | 0.93 | L3MBTL1 (0.40) | L3MBTL1KDM4EATMPTGER4DUSP3 | |
| SCHEMBL20149451 | 0.89 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMDUSP3IL1R1 | |
| SCHEMBL20149447 | 0.89 | L3MBTL1 (0.47) | L3MBTL1KDM4EATMDUSP3IL1R1 | |
| SCHEMBL20149465 | 0.88 | KDM4E (0.41) | L3MBTL1KDM4EATMPTGER4DUSP3 | |
| SCHEMBL19769467 | 0.87 | L3MBTL1 (0.39) | L3MBTL1KDM4EATMPTGER4IL1R1 | |
| SCHEMBL20821703 | 0.87 | L3MBTL1 (0.42) | L3MBTL1KDM4EATMPTGER4IL1R1 | |
| SCHEMBL22751039 | 0.86 | TDP2 (0.36) | L3MBTL1KDM4EATMPTGER4CYP11B1 | |
| SCHEMBL20149464 | 0.86 | CYP1A2 (0.38) | L3MBTL1KDM4EATMDUSP3ALDH1A1 | |
| SCHEMBL14900714 | 0.86 | L3MBTL1 (0.51) | L3MBTL1KDM4EATMPTGER4IL1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230139757-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230139757-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230023388-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
| US-20220173326-A1 | MELT MIXTURE FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2022-06-02 | — | — | US | disclosed |
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2018-05-17 | — | — | US | disclosed |
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180138420-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | EML4, LAGE3, KCNN4 | L3MBTL1 157/4885KDM4E 846/4885ATM 4565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.